Literature DB >> 6693498

A lipophilic iron chelator can replace transferrin as a stimulator of cell proliferation and differentiation.

W Landschulz, I Thesleff, P Ekblom.   

Abstract

Of the different growth supplements used in chemically defined media, only transferrin is required for differentiation of tubules in the embryonic mouse metanephros. Since transferrin is an iron-carrying protein, we asked whether iron is crucial for tubulogenesis. Differentiation of metanephric tubules both in whole embryonic kidneys and in a transfilter system was studied. The tissues were grown in chemically defined media containing transferrin, apotransferrin, the metal-chelator complex ferric pyridoxal isonicotinoyl hydrazone (FePIH), and excesses of ferric ion. Although we found that apotransferrin was not as effective as iron-loaded transferrin in promoting proliferation in the differentiating kidneys, excess ferric ion at up to 100 microM, five times the normal serum concentration, could not promote differentiation or proliferation. However, iron coupled to the nonphysiological, lipophilic iron chelator, pyridoxal isonicotinoyl hydrazone, to form FePIH, could sustain levels of cell proliferation and tubulogenesis similar to those attained by transferrin. Thus, the role of transferrin in cell proliferation during tubulogenesis is solely to provide iron. Since FePIH apparently bypasses the receptor-mediated route of iron intake, the use of FePIH as a tool for investigating cell proliferation and its regulation is suggested.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6693498      PMCID: PMC2113117          DOI: 10.1083/jcb.98.2.596

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  45 in total

1.  Binding of apotransferrin to K562 cells: explanation of the transferrin cycle.

Authors:  R D Klausner; G Ashwell; J van Renswoude; J B Harford; K R Bridges
Journal:  Proc Natl Acad Sci U S A       Date:  1983-04       Impact factor: 11.205

2.  pH and the recycling of transferrin during receptor-mediated endocytosis.

Authors:  A Dautry-Varsat; A Ciechanover; H F Lodish
Journal:  Proc Natl Acad Sci U S A       Date:  1983-04       Impact factor: 11.205

3.  Use of iron- or selenium-coupled monoclonal antibodies to cell-surface antigens as a positive selection system for cells.

Authors:  T Block; M Bothwell
Journal:  Nature       Date:  1983-01-27       Impact factor: 49.962

4.  A myotrophic protein from chick embryo extract: its purification, identity to transferrin, and indispensability for avian myogenesis.

Authors:  I Ii; I Kimura; E Ozawa
Journal:  Dev Biol       Date:  1982-12       Impact factor: 3.582

5.  Competitive advantage of diferric transferrin in delivering iron to reticulocytes.

Authors:  H A Huebers; E Csiba; E Huebers; C A Finch
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

6.  Ferric pyridoxal isonicotinoyl hydrazone can provide iron for heme synthesis in reticulocytes.

Authors:  P Ponka; H M Schulman; A Wilczynska
Journal:  Biochim Biophys Acta       Date:  1982-10-08

7.  Distribution of the transferrin receptor in normal human fibroblasts and fibrosarcoma cells.

Authors:  P Ekblom; I Thesleff; V P Lehto; I Virtanen
Journal:  Int J Cancer       Date:  1983-01-15       Impact factor: 7.396

8.  Transferrin protein and iron uptake by cultured hepatocytes.

Authors:  J C Sibille; J N Octave; Y J Schneider; A Trouet; R R Crichton
Journal:  FEBS Lett       Date:  1982-12-27       Impact factor: 4.124

9.  Transferrin as a fetal growth factor: acquisition of responsiveness related to embryonic induction.

Authors:  P Ekblom; I Thesleff; L Saxén; A Miettinen; R Timpl
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

10.  Receptor-mediated endocytosis of transferrin and recycling of the transferrin receptor in rat reticulocytes.

Authors:  C Harding; J Heuser; P Stahl
Journal:  J Cell Biol       Date:  1983-08       Impact factor: 10.539

View more
  14 in total

1.  Uptake and intracellular distribution of iron from transferrin and chelators in erythroid cells.

Authors:  G J Kontoghiorghes; A May
Journal:  Biol Met       Date:  1990

Review 2.  Gallium-containing anticancer compounds.

Authors:  Christopher R Chitambar
Journal:  Future Med Chem       Date:  2012-06       Impact factor: 3.808

3.  Immunocytochemical evidence for transferrin-dependent proliferation during renal tubulogenesis.

Authors:  S Fleming; D B Jones
Journal:  J Anat       Date:  1987-08       Impact factor: 2.610

4.  NADH-ascorbate free radical and -ferricyanide reductase activities represent different levels of plasma membrane electron transport.

Authors:  J M Villalba; A Canalejo; J C Rodríguez-Aguilera; M I Burón; D J Mooré; P Navas
Journal:  J Bioenerg Biomembr       Date:  1993-08       Impact factor: 2.945

5.  Serum-free culture of enriched mouse anterior and ventral prostatic epithelial cells in collagen gel.

Authors:  T Turner; H A Bern; P Young; G R Cunha
Journal:  In Vitro Cell Dev Biol       Date:  1990-07

6.  Species specificity of iron delivery in hybridomas.

Authors:  C R Ill; T Brehm; B K Lydersen; R Hernandez; K G Burnett
Journal:  In Vitro Cell Dev Biol       Date:  1988-05

7.  The effects of liposome-encapsulated and free clodronate on the growth of macrophage-like cells in vitro: the role of calcium and iron.

Authors:  J Mönkkönen; T D Heath
Journal:  Calcif Tissue Int       Date:  1993-08       Impact factor: 4.333

8.  Selection of cell lines resistant to anti-transferrin receptor antibody: evidence for a mutation in transferrin receptor.

Authors:  J F Lesley; R J Schulte
Journal:  Mol Cell Biol       Date:  1984-09       Impact factor: 4.272

9.  Growth of seminal vesicle epithelial cells in serum-free collagen gel culture.

Authors:  Y Tomooka; S E Harris; J A McLachlan
Journal:  In Vitro Cell Dev Biol       Date:  1985-04

10.  Giant eosinophil colonies from cultures of bone marrow cells.

Authors:  J H Butterfield; D Weiler
Journal:  In Vitro Cell Dev Biol       Date:  1986-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.